DAX24.302 ±0,0%Est505.827 -0,9%MSCI World4.343 -0,1%Top 10 Crypto10,09 +2,9%Nas25.114 +0,9%Bitcoin67.484 +0,7%Euro1,1699 -0,4%Öl111,8 +2,4%Gold4.559 -1,2%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 NVIDIA 918422 Siemens Energy ENER6Y SAP 716460 NEL ASA A0B733 Infineon 623100 BASF BASF11 Volkswagen (VW) vz. 766403 Deutsche Telekom 555750 Allianz 840400 Lufthansa 823212 Mercedes-Benz Group (ex Daimler) 710000 Amazon 906866 Novo Nordisk A3EU6F Microsoft 870747
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX stabil -- Autozölle belasten VW & Co. -- Berkshire Hathaway setzt mehr um -- GameStop will eBay übernehmen -- Xiaomi, E.ON, UBS, Merck, Rüstungsaktien im Fokus
Top News
Wasserstoff-Aktien im Fokus: Warum NEL steigt und Plug Power zurückbleibt Wasserstoff-Aktien im Fokus: Warum NEL steigt und Plug Power zurückbleibt
Experten sehen bei Munich Re-Aktie Potenzial Experten sehen bei Munich Re-Aktie Potenzial
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Penumbra Aktie

Kaufen
Verkaufen
Penumbra Aktien-Sparplan
275,60 EUR -1,80 EUR -0,65 %
STU
325,33 USD -1,05 USD -0,32 %
BTT
finanzen.net zero
Penumbra jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Marktkap.10,91 Mrd. EUR

KGV68,75Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA14Y65

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS70975L1070

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolPEN

Penumbra Aktien News

DatumMeistgelesen
PR NewswirePenumbra, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference
PR NewswirePenumbra, Inc. to Present at the Piper Sandler 37th Annual Healthcare Conference
PR NewswirePenumbra, Inc. Reports Third Quarter 2025 Financial Results
Wer­bungPenumbra-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
PR NewswireLatest Data from Landmark STORM-PE Randomized Controlled Trial Demonstrate that CAVT with Anticoagulation Significantly Improves Functional Outcomes for Patients with Pulmonary Embolism
PR NewswireLandmark STORM-PE Randomized Controlled Trial Finds Computer Assisted Vacuum Thrombectomy (CAVT) with Anticoagulation Superior to Traditional Anticoagulation Treatment for Pulmonary Embolism
PR NewswirePenumbra, Inc. Schedules Investor Event at TCT Conference on October 26, 2025; Earnings Release and Conference Call for Third Quarter 2025 Scheduled for November 5, 2025
PR NewswireNew Survey Shows Management of Blood Clots is Inconsistent, Even for Patients with the Same Risk Profile
PR NewswirePenumbra, Inc. Names Shruthi Narayan as Company President
PR NewswirePenumbra, Inc. to Present at Upcoming Investor Conferences
PR NewswirePenumbra, Inc. to Present at the Canaccord Genuity 45th Annual Growth Conference
PR NewswirePenumbra, Inc. Reports Second Quarter 2025 Financial Results
PR NewswirePenumbra, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call for July 29, 2025
PR NewswirePenumbra, Inc. Announces Completion of Enrollment for Landmark STORM-PE Randomized Controlled Trial
PR NewswirePenumbra Introduces the Ruby® XL System - the Longest, Largest, and Softest Coil on the Market for Vascular Embolization
PR NewswirePenumbra, Inc. to Present at Upcoming Investor Conferences
PR NewswirePenumbra, Inc. to Present at the BofA Securities 2025 Health Care Conference
PR NewswirePenumbra, Inc. Reports First Quarter 2025 Financial Results
PR NewswireSHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Penumbra, Inc. (NYSE: PEN)
PR NewswirePenumbra, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call for April 23, 2025
PR NewswireSeven New Data Sets Demonstrate Penumbra's Computer Assisted Vacuum Thrombectomy (CAVT) Technology Is Safe, Fast and Effective, Improves Patient Outcomes, and Delivers Healthcare Resource Benefits
PR NewswirePenumbra, Inc. Announces Don Kassing will Retire from Board of Directors
PR NewswirePenumbra, Inc. Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call for February 18, 2025
PR NewswirePenumbra, Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference
PR NewswirePenumbra, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference
PR NewswireNew Late Breaking Data Show Patients Treated with Penumbra's Computer Assisted Vacuum Thrombectomy Technology for Pulmonary Embolism Experience Shorter Hospital Stays and Fewer Complications Compa...
PR NewswirePenumbra, Inc. Reports Third Quarter 2024 Financial Results
PR NewswirePenumbra, Inc. Announces Completion of THUNDER IDE Study Enrollment for Acute Ischemic Stroke
PR NewswirePenumbra, Inc. Schedules Third Quarter 2024 Earnings Release and Conference Call for October 30, 2024
PR NewswirePenumbra Receives CE Mark for Computer Assisted Vacuum Thrombectomy Technologies - Lightning Flash™ 2.0 and Lightning Bolt™ 7 - in Europe
PR NewswirePenumbra, Inc. to Present at the Baird Global Healthcare Conference
PR NewswirePenumbra, Inc. to Present at the Wells Fargo Healthcare Conference
PR NewswirePenumbra, Inc. Announces $200 Million Share Repurchase Authorization
PR NewswirePenumbra, Inc. to Present at the Canaccord Genuity Growth Conference
PR NewswirePenumbra, Inc. Reports Second Quarter 2024 Financial Results
PR NewswirePenumbra, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for July 30, 2024
PR NewswirePenumbra, Inc. to Present at the Truist Securities MedTech Conference
PR NewswirePenumbra, Inc. to Present at the William Blair Growth Stock Conference
PR NewswirePenumbra, Inc. Reports First Quarter 2024 Financial Results
PR NewswirePenumbra, Inc. to Present at the RBC Capital Markets Global Healthcare Conference
PR NewswirePenumbra Launches Lightning Flash 2.0 - Latest CAVT Technology Designed to Rapidly Remove Blood Clots

Penumbra News

Penumbra News: auf dieser Seite finden Sie alle Penumbra News und Nachrichten zur Penumbra Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Penumbra News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Penumbra News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.